Algernon Pharmaceuticals Inc C.AGN

Recent News

[SkywalkerofLuke]

Was great to see the AGN.c AGNPF announcement Monday that the FDA granted Orphan Drug Designation to Ifenprodil (the lead clinical candidate being developed for the treatment of IPF and chronic cough) as a treatment for Idiopathic Pulmonary Fibrosis.

They recently concluded a Phase 2a study of Ifenprodil in patients with IPF. It saw patients receiving Ifenprodil experiencing no worsening of their lung function, and significant improvements were seen in the frequency of their IPF-associated cough as well.

With the recent focus on DMT as a treatment for strokes was good to see AGN still on a steady pace with ifenprodil. 

https://ir.algernonpharmaceuticals.com/news-events/press-releases/detail/169/algernon-pharmaceuticals-receives-u-s-fda-orphan-drug

[waves1]

This is a solid milestone for both AGN and IPF! ODD is only available for rare diseases affecting fewer than 200,000 patients in the US and qualifies sponsors for incentives including tax credits for qualified clinical trials and an exemption from users fees.   Plus, if an ODD product is granted approval, it will receive 7 years of market exclusivity! This sets AGN up quite well ahead of

[eiementai]

This post has been removed in accordance with Community Policy